v 3 Integrin-Dependent Antiangiogenic Activity of Resveratrol Stereoisomers

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-2351
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Biological and Molecular Properties of a New v 3/ v 5 Integrin Antagonist

Molecular Cancer Therapeutics
Cancer ResearchOncology
2005English

RGD-dependent Binding of TP508 to Integrin Αvβ3 Mediates Cell Adhesion and Induction of Nitric Oxide

Thrombosis and Haemostasis
Hematology
2010English

Integrin-Targeted AmpRGD Sunitinib Liposomes as Integrated Antiangiogenic Tools

Nanomedicine: Nanotechnology, Biology, and Medicine
Materials ScienceMolecular MedicineNanosciencePharmaceutical ScienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2019English

3-Integrin Regulates Vascular Endothelial Growth Factor-A-Dependent Permeability

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2004English

Integrin Α3β1 (VLA-3); Integrin Α5β1; Integrin Αvβ3

Science-Business eXchange
2009English

Multimodal Molecular Imaging of Integrin v 3 for in Vivo Detection of Pancreatic Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

Antiangiogenic Activity of 2-Deoxy-D-Glucose

PLoS ONE
Multidisciplinary
2010English

v 3-Integrin Relocalizes Nectin1 and Routes Herpes Simplex Virus to Lipid Rafts

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2011English

Energy-Dependent Effects of Resveratrol inSaccharomyces Cerevisiae

Yeast
Applied MicrobiologyGeneticsBiochemistryBioengineeringMedicineBiotechnology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy